Phase I study of GC33 in patients with Advanced Hepatocellular Carcinoma (HCC)
Latest Information Update: 25 May 2016
At a glance
- Drugs Codrituzumab (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 25 May 2016 New trial record